Best Peptides Company of 2024 Announced As Limitless Biotech
May 29, 2024 09:00 ET
|
Limitless Biotech
Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through...
Media Advisory: OFL to hold solidarity rally on Monday at U of T encampment to defend students’ right to protest
May 26, 2024 17:52 ET
|
Ontario Federation of Labour
Ontario labour unions to join solidarity rally with U of T student encampment in defence of protest rights, to demand admin rescind trespass order
Medical Polyoxymethylene Market Is Expected To Reach Revenue Of USD 253.5 Mn By 2033, at 7.4 % CAGR: Dimension Market Research
May 22, 2024 12:49 ET
|
Dimension Market Research
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview The Medical Polyoxymethylene Market size is expected to reach USD 133.6 million by 2024 and is further anticipated to value USD 253.5...
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
May 20, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...
Southeast Detox GA: Award Winning Suboxone Treatment Center in Rome, GA
May 16, 2024 09:00 ET
|
Southeast Detox GA
Rome, GA, May 16, 2024 (GLOBE NEWSWIRE) -- Southeast Detox GA, a leading inpatient alcohol and drug addiction rehab center, is excited to announce that its Rome Georgia in-patient detox facility has...
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
May 15, 2024 09:00 ET
|
Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
May 13, 2024 20:22 ET
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
PBC BioVet: Eine neue Dimension in der tierärztlichen Versorgung
May 12, 2024 20:05 ET
|
PBC Biomed Ltd
SHANNON, Irland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed ist stolz darauf, sein neuestes Unternehmen, PBC BioVet, vorzustellen: eine engagierte Tochtergesellschaft, die darauf abzielt, die...
Présentation de PBC BioVet : une nouvelle frontière dans les soins de santé vétérinaires
May 12, 2024 20:05 ET
|
PBC Biomed Ltd
SHANNON, Irlande, 13 mai 2024 (GLOBE NEWSWIRE) -- PBC Biomed est fier de dévoiler son tout nouveau projet, PBC BioVet, une filiale entièrement dédiée aux soins vétérinaires. Fermement résolu à...